Cetera Investment Advisers’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$337K Sell
10,719
-278
-3% -$11.7K ﹤0.01% 4053
2026
Q1
$608K Buy
10,997
+293
+3% +$13.9K ﹤0.01% 3329
2025
Q4
$400K Sell
10,704
-601
-5% -$24.4K ﹤0.01% 3638
2025
Q3
$457K Sell
11,305
-7,525
-40% -$249K ﹤0.01% 3449
2025
Q2
$481K Buy
18,830
+7,280
+63% +$159K ﹤0.01% 3001
2025
Q1
$247K Buy
11,550
+1,840
+19% +$41.1K ﹤0.01% 3434
2024
Q4
$204K Buy
+9,710
New +$225K ﹤0.01% 3417

Other funds holding PAHC

Cetera Investment Advisers's PAHC Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Phibro Animal Health (PAHC) stake by 2.5% in Q2 2026, selling an estimated $11.7K and leaving 10,719 shares worth $337K. The position accounts for ﹤0.01% of the portfolio, ranked #4053.

Cetera Investment Advisers first reported a position in PAHC in Q4 2024 and has held it in 7 quarters since. The position peaked at $608K in Q1 2026. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Cetera Investment Advisers held 10,719 shares of Phibro Animal Health worth $337K as of Q2 2026.
  • Cetera Investment Advisers sold 278 Phibro Animal Health shares in Q2 2026, an estimated $11.7K.
  • Phibro Animal Health made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4053 holding.
  • Cetera Investment Advisers first reported a position in Phibro Animal Health in Q4 2024 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Phibro Animal Health position peaked at $608K in Q1 2026.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.